Frequently asked questions
-
Click on the keywords to find related questions
Reviewed by
Prof. J Schalken - 2008/04/10
Reviewed by
Prof. J Schalken, Prof. H van Poppel and Prof. B Tombal - 2008/04/10
Reviewed by
Prof. J Schalken, Prof. H van Poppel and Prof. B Tombal - 2008/04/10
Reviewed by
Prof. H van Poppel and Prof. J Schalken - 2008/04/10
Reviewed by
Prof. H van Poppel, Prof. J Schalken and Prof. B Tombal - 2008/04/10
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2008/04/10
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/15
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
Reviewed by
Prof. Jack Schalken, Prof. Bertrand Tombal and Prof. Hendrik Van Poppel - 2007/11/16
|
-
Find the answer to all your questions about PCA3 in the frequently asked questions section
-
Use tools from research institutions developed to predict the risk of prostate cancer
|